Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study.

Author: Lu ZHANG ¹ ; Yi-Xuan LIU ¹ ; Zhe WANG ² ; Xiao-Qi WANG ² ; Jing-Jing ZHANG ¹ ; Rong-Huan JIANG ³ ; Xiang-Qun WANG ³ ; Shi-Wei ZHU ¹ ; Kun WANG ¹ ; Zuo-Jing LIU ¹ ; Huai-Qiu ZHU ² ; Li-Ping DUAN ¹
Author Information

1. Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.
2. Department of Biomedical Engineering, College of Engineering, and Center for Quantitative Biology, Peking University, Beijing 100871, China.
3. Department of Psychiatry, Institute of Mental Health, Peking University, Beijing 100191, China.
Publication Type:Journal Article
MeSH: Adolescent; Adult; Aged; Antidepressive Agents; therapeutic use; Body Mass Index; Depression; microbiology; Diarrhea; microbiology; Duloxetine Hydrochloride; therapeutic use; Feces; microbiology; Humans; Irritable Bowel Syndrome; drug therapy; microbiology; Middle Aged; Pilot Projects; Probiotics; therapeutic use; RNA, Ribosomal, 16S; genetics; Young Adult
From: Chinese Medical Journal 2019;132(3):346-351
CountryChina
Language:English